Treatment comments on lupus  nephritis: guidelines  and advances

doi:10.3969/j.issn.1004-583X.2016.05.002

Clinical Focus

Previous Articles Next Articles

Treatment comments on lupus nephritis: guidelines and advances

Key Laboratory of Rheumatology and Clinical Immunology， Department of Rheumatology and Clinical Immunology， Peking Union Medical College Hospital， Chinese Academy of Medical Sciences， Ministry of Education， Beijing 100730， China

Online:2016-05-05 Published:2016-05-04
Contact: Corresponding author: Zhang Wen，Email: zhangwen91@sina.com

Abstract

Abstract: Recently， great advances have been made in the treatment of lupus nephritis (LN). In 2012， the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR) published their respective recommendations and guidelines of LN treatment. From 2013， there have been a lot of novel credible results of clinical trials on LN treatment， which were updating rheumatologists' opinions. In this article， the authors analyzed the two classic recommendations and summarized the recent progresses in order to provide references for clinical treatment of LN.

Key words: lupus nephritis, proteinuria

Wang Li， Li Mengtao，Zhang Xuan，Zeng Xiaofeng，Zhang Wen， Zhang Fengchun. Treatment comments on lupus nephritis: guidelines and advances[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2016.05.002.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2016.05.002

https://huicui.hebmu.edu.cn/EN/Y2016/V31/I5/470

[1]	Wu Weijun, Chen Xiao, Wang Shaodan, Bu Laijun, Wu Xinchao, Yan Chenyang, Dong Gaiqin, Jiang Lijun, Wei Wenping. Analysis of screening data of urinalysis in 1973 students in Yangzhou [J]. Clinical Focus, 2023, 38(8): 702-705.
[2]	Jiang Ji, Zhu Xiaogang, Jiang Shan, Dawa Zhaba, Cen Qiang. Risk factors of proteinuria in hypertensive people living at high altitude for generations [J]. Clinical Focus, 2023, 38(12): 1086-1090.
[3]	Wang Lingling, Wu Jinlan, Wu Wei, Shen Shipeng, Chi Yanqing, Liu Maodong. A meta-analysis of the renal protective effects of vitamin D and its analogues in non dialysis patients with chronic kidney disease [J]. Clinical Focus, 2022, 37(12): 1081-1088.
[4]	Zhang Ming1, Li Wenzhe1, Li Yingying1, Fan Minghua2, Xing Guangqun1. Clinical value of dynamic monitoring of CD4+T lymphocyte count in treatment of lupus nephritis [J]. Clinical Focus, 2020, 35(9): 823-828.
[5]	He Jingjing，Qiao Yongxia， Wang Yanru，Liu Aijing. Advances in diagnosis and therapy of systemic lupus erythematosus [J]. Clinical Focus, 2016, 31(5): 475-481.
[6]	Nan Cailing， Zhang Weiyang， Yao Yaning. Value of virtual touch tissue quantification technique in systemic lupus nephritis [J]. Clinical Focus, 2016, 31(11): 1240-1243.
[7]	Li Wenru;Xing Guangqun. Effect of contact system and neutrophil extracellular traps in pathogenesis of lupus nephritis [J]. Clinical Focus, 2015, 30(6): 653-656.
[8]	Bao Zhiwei;Yu Yean;Jiang Huajun. Influence of renal function and proteinuria on cardiovascular events in octogenarian population [J]. Clinical Focus, 2015, 30(4): 372-375.
[9]	Wang Chunhua. Effect of alprostadil combined with Sanqi Panax Notoginseng Injection on proteinuria in early diabetic nephropathy [J]. Clinical Focus, 2015, 30(12): 1410-1412.
[10]	LI Hong-bo;ZHANG Jing-kun;WU Chao;WANG Ji;ZHANG Yu-jun;GAO Li-xia. Relationship of high mobility group protein 1,Toll-like receptors 4, vascular endothelial cell adhesion molecule-1 expression in lupus nephritis with dyslipidemia [J]. Clinical Focus, 2014, 29(8): 891-895.
[11]	FU Shu-xia. Clinical main advances in kidney disease researches during 2013 [J]. CLINICAL FOCUS, 2014, 29(3): 252-260.

Treatment comments on lupus nephritis: guidelines and advances

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 11

Recommended Articles

Metrics

Comments